▶ 調査レポート

世界のパゾパニブ市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Pazopanib Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

が調査・発行した産業分析レポートです。世界のパゾパニブ市場 2021:企業別、地域別、種類・用途別 / Global Pazopanib Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-105X13368資料のイメージです。• レポートコード:GIR-105X13368
• 出版社/出版日: / 2021年5月
• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:Pharma & Healthcare
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、パゾパニブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。パゾパニブの種類別市場規模(200mg錠、400mg錠)、用途別市場規模(腎細胞がん、軟部肉腫、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・パゾパニブの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Novartis、GlaxoSmithKline
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:200mg錠、400mg錠
・用途別分析2016年-2026年:腎細胞がん、軟部肉腫、その他
・パゾパニブの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・パゾパニブのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・パゾパニブのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・パゾパニブの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・パゾパニブの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Pazopanib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Pazopanib size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Pazopanib market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Pazopanib market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
200mg Tables
400mg Tables

Market segment by Application can be divided into
Renal Cell Carcinoma
Soft Tissue Sarcoma
Other

The key market players for global Pazopanib market are listed below:
Novartis
GlaxoSmithKline

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Pazopanib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pazopanib Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 200mg Tables
1.2.3 400mg Tables
1.3 Market Analysis by Application
1.3.1 Overview: Global Pazopanib Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Renal Cell Carcinoma
1.3.3 Soft Tissue Sarcoma
1.3.4 Other
1.4 Global Pazopanib Market Size & Forecast
1.4.1 Global Pazopanib Sales in Value (2016-2026))
1.4.2 Global Pazopanib Sales in Volume (2016-2026)
1.4.3 Global Pazopanib Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Pazopanib Production Capacity Analysis
1.5.1 Global Pazopanib Total Production Capacity (2016-2026)
1.5.2 Global Pazopanib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pazopanib Market Drivers
1.6.2 Pazopanib Market Restraints
1.6.3 Pazopanib Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Pazopanib Product and Services
2.1.4 Novartis Pazopanib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Pazopanib Product and Services
2.2.4 GlaxoSmithKline Pazopanib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Pazopanib Sales by Manufacturer
3.1 Global Pazopanib Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pazopanib Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pazopanib
3.4 Market Concentration Rate
3.4.1 Top 3 Pazopanib Manufacturer Market Share
3.4.2 Top 6 Pazopanib Manufacturer Market Share
3.5 Global Pazopanib Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pazopanib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pazopanib Market Size by Region
4.1.1 Global Pazopanib Sales in Volume by Region (2016-2026)
4.1.2 Global Pazopanib Revenue by Region (2016-2026)
4.2 North America Pazopanib Revenue (2016-2026)
4.3 Europe Pazopanib Revenue (2016-2026)
4.4 Asia-Pacific Pazopanib Revenue (2016-2026)
4.5 South America Pazopanib Revenue (2016-2026)
4.6 Middle East and Africa Pazopanib Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pazopanib Sales in Volume by Type (2016-2026)
5.2 Global Pazopanib Revenue by Type (2016-2026)
5.3 Global Pazopanib Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pazopanib Sales in Volume by Application (2016-2026)
6.2 Global Pazopanib Revenue by Application (2016-2026)
6.3 Global Pazopanib Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pazopanib Sales by Type (2016-2026)
7.2 North America Pazopanib Sales by Application (2016-2026)
7.3 North America Pazopanib Market Size by Country
7.3.1 North America Pazopanib Sales in Volume by Country (2016-2026)
7.3.2 North America Pazopanib Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pazopanib Sales by Type (2016-2026)
8.2 Europe Pazopanib Sales by Application (2016-2026)
8.3 Europe Pazopanib Market Size by Country
8.3.1 Europe Pazopanib Sales in Volume by Country (2016-2026)
8.3.2 Europe Pazopanib Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pazopanib Sales by Type (2016-2026)
9.2 Asia-Pacific Pazopanib Sales by Application (2016-2026)
9.3 Asia-Pacific Pazopanib Market Size by Region
9.3.1 Asia-Pacific Pazopanib Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pazopanib Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pazopanib Sales by Type (2016-2026)
10.2 South America Pazopanib Sales by Application (2016-2026)
10.3 South America Pazopanib Market Size by Country
10.3.1 South America Pazopanib Sales in Volume by Country (2016-2026)
10.3.2 South America Pazopanib Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pazopanib Sales by Type (2016-2026)
11.2 Middle East & Africa Pazopanib Sales by Application (2016-2026)
11.3 Middle East & Africa Pazopanib Market Size by Country
11.3.1 Middle East & Africa Pazopanib Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pazopanib Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pazopanib Typical Distributors
12.3 Pazopanib Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Pazopanib Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pazopanib Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Pazopanib Product and Services
Table 6. Novartis Pazopanib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline Pazopanib Product and Services
Table 10. GlaxoSmithKline Pazopanib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Global Pazopanib Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 12. Global Pazopanib Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 13. Market Position of Manufacturers in Pazopanib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 14. Global Pazopanib Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 15. Head Office and Pazopanib Production Site of Key Manufacturer
Table 16. Global Pazopanib Sales by Region (2016-2021e) & (K Pcs)
Table 17. Global Pazopanib Sales by Region (2021-2026) & (K Pcs)
Table 18. Global Pazopanib Revenue by Region (2016-2021e) & (USD Million)
Table 19. Global Pazopanib Revenue by Region (2021-2026) & (USD Million)
Table 20. Global Pazopanib Sales by Type (2016-2021e) & (K Pcs)
Table 21. Global Pazopanib Sales by Type (2021-2026) & (K Pcs)
Table 22. Global Pazopanib Revenue by Type (2016-2021e) & (USD Million)
Table 23. Global Pazopanib Revenue by Type (2021-2026) & (USD Million)
Table 24. Global Pazopanib Price by Type (2016-2021e) & (USD/Pcs)
Table 25. Global Pazopanib Price by Type (2021-2026) & (USD/Pcs)
Table 26. Global Pazopanib Sales by Application (2016-2021e) & (K Pcs)
Table 27. Global Pazopanib Sales by Application (2021-2026) & (K Pcs)
Table 28. Global Pazopanib Revenue by Application (2016-2021e) & (USD Million)
Table 29. Global Pazopanib Revenue by Application (2021-2026) & (USD Million)
Table 30. Global Pazopanib Price by Application (2016-2021e) & (USD/Pcs)
Table 31. Global Pazopanib Price by Application (2021-2026) & (USD/Pcs)
Table 32. North America Pazopanib Sales by Country (2016-2021e) & (K Pcs)
Table 33. North America Pazopanib Sales by Country (2021-2026) & (K Pcs)
Table 34. North America Pazopanib Revenue by Country (2016-2021e) & (USD Million)
Table 35. North America Pazopanib Revenue by Country (2021-2026) & (USD Million)
Table 36. North America Pazopanib Sales by Type (2016-2021e) & (K Pcs)
Table 37. North America Pazopanib Sales by Type (2021-2026) & (K Pcs)
Table 38. North America Pazopanib Sales by Application (2016-2021e) & (K Pcs)
Table 39. North America Pazopanib Sales by Application (2021-2026) & (K Pcs)
Table 40. Europe Pazopanib Sales by Country (2016-2021e) & (K Pcs)
Table 41. Europe Pazopanib Sales by Country (2021-2026) & (K Pcs)
Table 42. Europe Pazopanib Revenue by Country (2016-2021e) & (USD Million)
Table 43. Europe Pazopanib Revenue by Country (2021-2026) & (USD Million)
Table 44. Europe Pazopanib Sales by Type (2016-2021e) & (K Pcs)
Table 45. Europe Pazopanib Sales by Type (2021-2026) & (K Pcs)
Table 46. Europe Pazopanib Sales by Application (2016-2021e) & (K Pcs)
Table 47. Europe Pazopanib Sales by Application (2021-2026) & (K Pcs)
Table 48. Asia-Pacific Pazopanib Sales by Region (2016-2021e) & (K Pcs)
Table 49. Asia-Pacific Pazopanib Sales by Region (2021-2026) & (K Pcs)
Table 50. Asia-Pacific Pazopanib Revenue by Region (2016-2021e) & (USD Million)
Table 51. Asia-Pacific Pazopanib Revenue by Region (2021-2026) & (USD Million)
Table 52. Asia-Pacific Pazopanib Sales by Type (2016-2021e) & (K Pcs)
Table 53. Asia-Pacific Pazopanib Sales by Type (2021-2026) & (K Pcs)
Table 54. Asia-Pacific Pazopanib Sales by Application (2016-2021e) & (K Pcs)
Table 55. Asia-Pacific Pazopanib Sales by Application (2021-2026) & (K Pcs)
Table 56. South America Pazopanib Sales by Country (2016-2021e) & (K Pcs)
Table 57. South America Pazopanib Sales by Country (2021-2026) & (K Pcs)
Table 58. South America Pazopanib Revenue by Country (2016-2021e) & (USD Million)
Table 59. South America Pazopanib Revenue by Country (2021-2026) & (USD Million)
Table 60. South America Pazopanib Sales by Type (2016-2021e) & (K Pcs)
Table 61. South America Pazopanib Sales by Type (2021-2026) & (K Pcs)
Table 62. South America Pazopanib Sales by Application (2016-2021e) & (K Pcs)
Table 63. South America Pazopanib Sales by Application (2021-2026) & (K Pcs)
Table 64. Middle East & Africa Pazopanib Sales by Country (2016-2021e) & (K Pcs)
Table 65. Middle East & Africa Pazopanib Sales by Country (2021-2026) & (K Pcs)
Table 66. Middle East & Africa Pazopanib Revenue by Country (2016-2021e) & (USD Million)
Table 67. Middle East & Africa Pazopanib Revenue by Country (2021-2026) & (USD Million)
Table 68. Middle East & Africa Pazopanib Sales by Type (2016-2021e) & (K Pcs)
Table 69. Middle East & Africa Pazopanib Sales by Type (2021-2026) & (K Pcs)
Table 70. Middle East & Africa Pazopanib Sales by Application (2016-2021e) & (K Pcs)
Table 71. Middle East & Africa Pazopanib Sales by Application (2021-2026) & (K Pcs)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Pazopanib Typical Distributors
Table 75. Pazopanib Typical Customers
List of Figures
Figure 1. Pazopanib Picture
Figure 2. Global Pazopanib Sales Market Share by Type in 2020
Figure 3. 200mg Tables
Figure 4. 400mg Tables
Figure 5. Global Pazopanib Sales Market Share by Application in 2020
Figure 6. Renal Cell Carcinoma
Figure 7. Soft Tissue Sarcoma
Figure 8. Other
Figure 9. Global Pazopanib Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 10. Global Pazopanib Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Pazopanib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Pazopanib Sales (2016-2026) & (K Pcs)
Figure 31. Global Pazopanib Production Capacity (2016-2026) & (K Pcs)
Figure 32. Global Pazopanib Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Pazopanib Market Drivers
Figure 34. Pazopanib Market Restraints
Figure 35. Pazopanib Market Trends
Figure 36. Global Pazopanib Sales Market Share by Manufacturer in 2020
Figure 37. Global Pazopanib Revenue Market Share by Manufacturer in 2020
Figure 38. Pazopanib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Pazopanib Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Pazopanib Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Pazopanib Sales Market Share by Region (2016-2026)
Figure 42. Global Pazopanib Revenue Market Share by Region (2016-2026)
Figure 43. North America Pazopanib Revenue (2016-2026) & (USD Million)
Figure 44. Europe Pazopanib Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Pazopanib Revenue (2016-2026) & (USD Million)
Figure 46. South America Pazopanib Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Pazopanib Revenue (2016-2026) & (USD Million)
Figure 48. Global Pazopanib Sales Market Share by Type (2016-2026)
Figure 49. Global Pazopanib Revenue Market Share by Type (2016-2026)
Figure 50. Global Pazopanib Price by Type (2016-2026) & (USD/Pcs)
Figure 51. Global Pazopanib Sales Market Share by Application (2016-2026)
Figure 52. Global Pazopanib Revenue Market Share by Application (2016-2026)
Figure 53. Global Pazopanib Price by Application (2016-2026) & (USD/Pcs)
Figure 54. North America Pazopanib Sales Market Share by Country (2016-2026)
Figure 55. North America Pazopanib Revenue Market Share by Country (2016-2026)
Figure 56. North America Pazopanib Sales Market Share by Type (2016-2026)
Figure 57. North America Pazopanib Sales Market Share by Application (2016-2026)
Figure 58. Europe Pazopanib Sales Market Share by Country (2016-2026)
Figure 59. Europe Pazopanib Revenue Market Share by Country (2016-2026)
Figure 60. Europe Pazopanib Sales Market Share by Type (2016-2026)
Figure 61. Europe Pazopanib Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Pazopanib Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Pazopanib Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Pazopanib Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Pazopanib Sales Market Share by Application (2016-2026)
Figure 66. South America Pazopanib Sales Market Share by Country (2016-2026)
Figure 67. South America Pazopanib Revenue Market Share by Country (2016-2026)
Figure 68. South America Pazopanib Sales Market Share by Type (2016-2026)
Figure 69. South America Pazopanib Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Pazopanib Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Pazopanib Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Pazopanib Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Pazopanib Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source